Trademark: 79184200
Word
ENDOLUCINBETA
Status Date
Wednesday, November 30, 2016
Filing Date
Thursday, January 14, 2016
Abandoned Date
Monday, November 7, 2016
5 Radiopharmaceutical products, namely, precursors containing lutetium; radioactive substances for medical purposes
Color is not claimed as a feature of the mark.
ENDOLUCIN BETA
Nov 26, 2021
Change Of Name/Address Rec'd From Ib
Oct 21, 2021
New Representative At Ib Received
Dec 15, 2017
Final Decision Transaction Processed By Ib
Nov 30, 2017
Final Disposition Notice Sent To Ib
Nov 30, 2017
Final Disposition Notice Created, To Be Sent To Ib
Sep 1, 2017
Notification Of Possible Opposition - Processed By Ib
Aug 16, 2017
Notification Of Possible Opposition Sent To Ib
Aug 16, 2017
Notification Of Possible Opposition Created, To Be Sent To Ib
Nov 30, 2016
Abandonment Notice Mailed - Failure To Respond
Nov 30, 2016
Abandonment - Failure To Respond Or Late Response
May 19, 2016
Refusal Processed By Ib
May 4, 2016
Non-Final Action Mailed - Refusal Sent To Ib
May 4, 2016
Refusal Processed By Mpu
May 4, 2016
Non-Final Action (Ib Refusal) Prepared For Review
May 3, 2016
Non-Final Action Written
May 2, 2016
Assigned To Examiner
Mar 15, 2016
Application Filing Receipt Mailed
Mar 11, 2016
New Application Office Supplied Data Entered In Tram
Mar 10, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
